CD BIOPARTICLES

Company Snapshot

Founded: 2010
Entity Type: Private
Region: U.S.
Headquarter: New York, U.S.
Key Geographics: North America, Europe
Corporate Address: 45-1 Ramsey Road Shirley, New York 11967 U.S. Tel. +1-631-633-6938 www.cd-bioparticles.com

Company Overview

CD Bioparticles manufactures and supplies nanoparticles, microparticles, and coatings for R&D and commercialization in vitro diagnostics, biochemistry, battery analysis, and cell separation. The company offers high-quality magnetic particles, gold nanoparticles, silica particles, polymer particles, quantum dots, bead-based conjugation kits, magnetic separation kits, and more. It provides quantum dots, including carbon quantum dots and graphene quantum dots, in ultrahigh purity that can be used as a part of the battery electrodes or electrolytes to increase the conductivity, stability, and overall energy storage performance.

CD BIOPARTICLES In Reports

Global Quantum Batteries Market

BCC Research Market Analyst says global quantum battery market was valued at $18.5 million in 2024 and is projected to reach $65.4 million by the end of 2030.

Metal-organic Frameworks: Global Markets

BCC Research Market Analyst says global market for metal-organic frameworks is expected to grow from $459.6 million in 2024 to $949.2 million by the end of 2029, at a CAGR of 15.6%

Company's Business Segments

  • Magnetic Particles and Nanoparticles : The company provides advanced drug delivery services and products, including custom nanoparticle formulations like lipid and polymer nanoparticles, and other nanotechnology-based solutions for drug development.

Applications/End User Industries

  • Biomedical Applications
  • Other Industries
AI Sentiment